Pain and Painkillers

1785 Words4 Pages

Like a “bell-ringing mechanism in a church”. That is how, in 1664, Descartes (Jackson, 2002) suggested pain should be visualized. This, however, is a very primitive description of the phenomenon of pain.

Injury or inflammation of a bodily tissue can lead to profound changes in the internal chemical environment. Damaged cells discharge their intracellular components, releasing substances, notably ATP, potassium ions (K+) and acetyl chloine (ACh). Some of these contents act on nociceptors directly, triggering an action potential which will end up in the brain. Other components released from the cells can sensitize the terminals, making them hypersensitive to further stimuli. This allows a pain signal to be transmitted when a seemingly insignificant concentration of, for example ATP (released in millimolar quantities), is introduced to the extracellular space.

Prostaglandins, of which many pain receptors are especially sensitive, are produced at the site of injury. Arachidonic acid is generated by the cells and this in turn is converted to prostaglandins. Cyclooxygenase-2 (COX-2) converts the acid to prostaglandin H which in turn can be converted to specific prostanoids, such as prostaglandin E2. As Woolf (2004) noted, prostaglandin E2 can be detected by prostaglandin E receptors, causing sensitisation without directly producing pain. He tells us how it takes bradykinin, taken up by its B2 receptor, to activate the notion of pain. This instance highlights how complex pain sensations can be, and, whilst we may wonder why such a mechanism is necessary, we can learn to exploit the system by producing painkillers that hinder a specific step, thus having a vast ‘numbing’ knock-on effect.

There are many heat-sensitive receptors in our b...

... middle of paper ...

...29 – 836.

Riordan M, Rylance G, Berry K (2002), Poisoning in Children 2: Painkillers. Arch Dis Child. 87: 397 – 399.

Roth GJ, Majerus PW (1975), The Mechanism of the Effect of Aspirin on Human Platelets: 1 Acetylation of a particulate fraction protein. J Clin Invest. 56: 624 – 632.

Smith WL (1989), The Eicosanoids and their Biochemical Mechanisms of Action. J Biol Chem. 259: 315– 324.

Streltzer J (2001), Pain Management in the Opioid-dependent Patient. Current Psychiatry Reports, 3: 489–496.

Weber C, Erl W, Pietsch A, Weber PC (1995), Aspirin inhibits nuclear factor- κB mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation 91: 1914 – 1917.

Woolf CJ (2004), Pain: Moving from Symptom Control toward Mechanism-Specific Pharmacologic Management. Physiology in Medicine: A Series of Articles Linking Medicine with Science. 140: 445 – 447.

Open Document